Form D · Pharmaceuticals
TruTag Technologies, Inc.
Emeryville, CA · CIK 0001560969
Offering snapshot reported Nov 24, 2021 · SEC filing
- Reported sold
- $14.7M Offering amount: $24.2M
- Investors reported
- 12 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Nov 12, 2021 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Nov 24, 2021 | Initial | $14,692,572 | No comparison | 12 | SEC filing |
| Sep 3, 2019 | Initial | $25,471,113 | No comparison | 30 | SEC filing |
| Jun 13, 2014 | Amendment | $16,776,527 | $7,499,959vs Oct 26, 2012 | 53 | SEC filing |
| Oct 26, 2012 | Amendment | $9,276,568 | $0vs Oct 25, 2012 | 52 | SEC filing |
| Oct 25, 2012 | Initial | $9,276,568 | No comparison | 52 | SEC filing |
Offering details
- Securities
- Equity, Other
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-422427
Items 13(a) and 13(b) above include the principal and interest on Notes in aggregate amount of $4,242,590.
Convertible Promissory Notes ("Notes"), Series D, Series D-1 & Series D-2 Preferred Stock ("Series D"), the underlying shares of Series D issuable upon conversion of Notes & the underlying shares of Common Stock issuable upon conversion of Series D.
Source: Form D, filed Nov 24, 2021. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| George Ariyoshi | Director |
| Michael Bartholomeusz | Director, Executive |
| Matthew Cohen | Director |
| Sean Karamchandani | Director |
| Leslie Leff | Director |
| Gregory Leong | Director |
| Mark Maciejewski | Director |
| Kent Mansfield | Executive |
| Jennifer Mc Farlane | Director |
| Michael O'neill, Ph.D. | Executive |
| James Pappas | Director |
| Albert Pleus | Director |
| Jeffrey Watanabe | Director |
| Barry Weinman | Director |
| Peter M. O. Wong | Executive |
| Hank C.K. Wuh, M.D. | Director, Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
2200 Powell Street #1035
Emeryville, CA, 94608
Emeryville, CA, 94608